• Abeona Launches Phase 3 Trial Testing EB-101 Cell Therapy for RDEB
  • It’s My Body: Why Unsolicited Comments Can Be Hurtful
  • Castle Creek Acquires Fibrocell, Now Leading Development of FCX-007 Gene Therapy for RDEB
  • Research Consortium Receives $1.6M to Develop Stem Cell Therapies for Skin Diseases
  • Spray Therapy APR-TD011 Earns FDA Orphan Drug Designation to Treat EB
  • All I Want for Christmas Is Everything I Already Have
  • FDA Clears Phase 3 Trial Testing EB-101 Cell Therapy for Severe Blistering Skin Disorder
  • Gene Therapy Takes Center Stage at 2019 NORD Summit
  • HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
  • New COL7A1 Gene Mutation Found in Rare DEB Subtype, Study Shows
  • Precautions Can Help Ensure Safe Pregnancy, Delivery in Women With EB Simplex, Study Reports
  • I Look Forward to Telling My Epidermolysis Bullosa Story